Manulife (Manufacturers Life Insurance)
ALXN

Manulife (Manufacturers Life Insurance)’s Alexion Pharmaceuticals ALXN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,045,496
Closed -$192M – 3306
2021
Q2 		$192M Sell
1,045,496
-368,797
-26% -$63.3M 0.16% 149
2021
Q1 		$216M Sell
1,414,293
-1,390,053
-50% -$215M 0.19% 129
2020
Q4 		$438M Buy
2,804,346
+1,024,729
+58% +$132M 0.4% 55
2020
Q3 		$204M Sell
1,779,617
-33,041
-2% -$3.56M 0.21% 111
2020
Q2 		$202M Buy
1,812,658
+41,654
+2% +$4.42M 0.19% 113
2020
Q1 		$159M Buy
1,771,004
+326,064
+23% +$32M 0.18% 128
2019
Q4 		$156M Buy
1,444,940
+82,008
+6% +$8.77M 0.16% 153
2019
Q3 		$133M Buy
1,362,932
+186,201
+16% +$21M 0.15% 156
2019
Q2 		$154M Buy
1,176,731
+174,256
+17% +$22.5M 0.18% 136
2019
Q1 		$136M Sell
1,002,475
-40,764
-4% -$5.07M 0.15% 159
2018
Q4 		$102M Buy
1,043,239
+348,048
+50% +$41.1M 0.13% 183
2018
Q3 		$96.6M Buy
695,191
+33,428
+5% +$4.19M 0.1% 202
2018
Q2 		$82.2M Buy
661,763
+444,686
+205% +$52M 0.09% 223
2018
Q1 		$24.2M Sell
217,077
-55,887
-20% -$6.68M 0.03% 522
2017
Q4 		$32.6M Buy
272,964
+25,254
+10% +$3.08M 0.04% 441
2017
Q3 		$34.8M Buy
247,710
+462
+0.2% +$62.8K 0.04% 410
2017
Q2 		$30.1M Buy
247,248
+2,255
+0.9% +$262K 0.04% 449
2017
Q1 		$29.7M Buy
244,993
+11,289
+5% +$1.46M 0.04% 447
2016
Q4 		$28.6M Buy
233,704
+10,677
+5% +$1.31M 0.04% 396
2016
Q3 		$27.3M Buy
223,027
+7,339
+3% +$945K 0.04% 385
2016
Q2 		$25.2M Buy
215,688
+9,387
+5% +$1.33M 0.04% 388
2016
Q1 		$27.8M Sell
206,301
-119,090
-37% -$17.5M 0.02% 370
2015
Q4 		$62.1K Sell
325,391
-70,737
-18% -$12.4M 0.06% 210
2015
Q3 		$62K Sell
396,128
-10,253
-3% -$1.87M 0.07% 212
2015
Q2 		$73.5K Buy
406,381
+29,126
+8% +$5.03M 0.09% 180
2015
Q1 		$65.4K Buy
377,255
+25,439
+7% +$4.6M 0.08% 191
2014
Q4 		$65.1K Sell
351,816
-3,011
-0.8% -$558K 0.09% 175
2014
Q3 		$58.8K Sell
354,827
-1,233
-0.3% -$202K 0.09% 192
2014
Q2 		$55.6M Buy
356,060
+25,937
+8% +$4.1M 0.08% 199
2014
Q1 		$50.2K Sell
330,123
-67,844
-17% -$10.8M 0.08% 220
2013
Q4 		$53K Buy
397,967
+17,146
+5% +$2.06M 0.08% 200
2013
Q3 		$44.2K Sell
380,821
-32,977
-8% -$3.62M 0.07% 223
2013
Q2 		$38.2M Buy
+413,798
New +$39.9M 0.07% 228

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ALXN Position: Q3 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,045,496 shares — an estimated $192M sold.

Manulife (Manufacturers Life Insurance) first reported a position in ALXN in Q2 2013 and held it in 33 quarters. The position peaked at $438M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 1,045,496 Alexion Pharmaceuticals shares in Q3 2021, an estimated $192M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 33 quarters.
  • Manulife (Manufacturers Life Insurance)'s Alexion Pharmaceuticals position peaked at $438M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.